GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redwood Scientific Technologies Inc (OTCPK:RSCI) » Definitions » Cash-to-Debt

Redwood Scientific Technologies (Redwood Scientific Technologies) Cash-to-Debt : N/A (As of Dec. 2022)


View and export this data going back to 2008. Start your Free Trial

What is Redwood Scientific Technologies Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Redwood Scientific Technologies's cash to debt ratio for the quarter that ended in Dec. 2022 was N/A.

The historical rank and industry rank for Redwood Scientific Technologies's Cash-to-Debt or its related term are showing as below:

RSCI's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.93
* Ranked among companies with meaningful Cash-to-Debt only.

Redwood Scientific Technologies Cash-to-Debt Historical Data

The historical data trend for Redwood Scientific Technologies's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Redwood Scientific Technologies Cash-to-Debt Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22
Cash-to-Debt
N/A N/A N/A

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22
Cash-to-Debt N/A N/A N/A

Competitive Comparison of Redwood Scientific Technologies's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's Cash-to-Debt falls into.


Redwood Scientific Technologies Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Redwood Scientific Technologies's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Redwood Scientific Technologies's Cash to Debt Ratio for the quarter that ended in Dec. 2022 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies  (OTCPK:RSCI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Redwood Scientific Technologies Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Redwood Scientific Technologies's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Redwood Scientific Technologies (Redwood Scientific Technologies) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Redwood Scientific Technologies Inc (OTCPK:RSCI) » Definitions » Cash-to-Debt
Comparable Companies
HSTI BOM:512101 BOM:524322 BOM:524661 BOM:531686 TSXV:CIP.H BOM:524516 XCNQ:WRW BKIT BOM:531521 BOM:531015 XCNQ:DYME BOM:524606 BOM:526075 XCNQ:MJRX BOM:531762 YBAO XCNQ:RLSC BOM:533157 BOM:539680
Traded in Other Exchanges
N/A
Address
810 North Mountain Avenue, Suite 100, Upland, CA, USA, 91786
Website
https://www.redwoodsci.co
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets FDA-registered consumer homeopathic drugs and supplements. It utilized patent-pending sublingual strip delivery technology. It offers a product called TBX-FREE which is an oral strip that helps smokers safely and effectively eliminate the craving to smoke.